1Nakamura S, Matsumoto T, Lida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends[J].Cancer,2003,97(10):2462-2473.
7Zucca E,Conconi A,Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoma tissue [J]. Blood,2003,101(7) :2489-2495.
8Kaneko Y, Sakurai S, Hironaka M, et al. Distrinct methylated profiles in helicobacter pylori dependent and independent gastric MALT lymphomas[J]. Gut,2003,52(5) :641-646.
2Baens M, Maes B, Steyls A et al. The product of the t(11;18), an API2-MLT fusion, marks nearly haly of gastric MALT type lymphomas without large cell proliferation[J]. Am J Pathol,2000,156(4):1433-1439.
3Ohshima K, Muta H, Kawasaki C et al. Bcl10 expression, rearrangement and mutation in MALT lymphoma:correlation with expression of nuclear factor-kappaB[J]. Int J Oncol, 2001,19(2):283-289.
4Liu H, Ye H,Dogan A et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10[J]. Blood,2001,98(4):1182-1187.
6Lin K, Sherrington PD, Dennis M et al. Relationship between p53 dysfunction,CD38 expression, and IgVH mutation in chronic lymphocytic leukemia[J]. Blood,2002,100(4):1404-1409.
7Shaffer AL, Yu X, He Y et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control[J]. Immunity,2000,13(2):199-212.
8Rosenwald A, Wright G, Chan WC et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma[J]. N Engl J Med,2002,346(25):1937-1947.
9Lossos IS, Jones CD, Warnke R et al. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma[J]. Blood,2001,98(4):945-951.
